University of Kansas Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Kansas Medical Center sits in the top decile of US sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count).

408 total trials 93 currently recruiting 252 completed early-phase tilt top decile by trial count

University of Kansas Medical Center: 408 sponsored US clinical trials, 93 recruiting.

University of Kansas Medical Center sponsors 408 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 252 completed. 28 of these trials are in Phase 3-4 (later-stage) and 85 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Smoking Cessation, with 9 trials.

Top-decile sponsor footprint

University of Kansas Medical Center ranks in the top decile of sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

252 of 275 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

408 total, page 5 of 9

COMPLETED NA

Trial of Antimicrobial Restraint in Presumed Pneumonia

NCT04438187

TERMINATED NA

MOD Diet in Gestational Diabetes Mellitus

NCT04570111

COMPLETED

Blood Flow Response and Acute INterval Exercise

NCT04673994

COMPLETED

Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density

NCT04801498

COMPLETED NA

KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice

NCT04763824

COMPLETED NA

Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline

NCT04585880

COMPLETED NA

Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT

NCT04297787

COMPLETED NA

Comparative Abuse Liability Among African American and White Smokers

NCT04646668

COMPLETED NA

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

NCT05370053

COMPLETED NA

Acute Exercise and the Cerebral Metabolic Response in Aging and Alzheimer's Disease

NCT04299308

COMPLETED Phase 1

Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis

NCT04421677

COMPLETED

Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer

NCT06337305

COMPLETED NA

Utilization of PTNS During Office-Based Cystoscopy

NCT04440579

TERMINATED NA

Heat Shock Therapy to Improve Mitochondrial Function in Neuropathy

NCT05070741

COMPLETED Phase 2

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

NCT04481685

COMPLETED NA

The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral

NCT07580482

COMPLETED NA

Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes

NCT04566588

COMPLETED Phase 1

Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population

NCT02077010

COMPLETED

Diagnostic Value of Weight Bearing CT for Detecting Meniscal Tears

NCT04430829

COMPLETED NA

Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation

NCT04382430

COMPLETED Phase 1

Study of Open Label Losartan in COVID-19

NCT04335123

COMPLETED

The Impact of Preoperative Urostomy Education on Patients and Families

NCT04334226

COMPLETED NA

Effects of Innovative Aerobic Exercise Training in Cystic Fibrosis

NCT04543929

COMPLETED NA

Weight Loss Physical Disabilities

NCT04046471

TERMINATED Phase 4

Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction

NCT04347122

COMPLETED NA

The Promotion of Physical Activity for the Prevention of Alzheimer's Disease in Adults With Down Syndrome

NCT04048759

COMPLETED

Accuracy of TCOM vs NIRS in Predicting Wound Outcomes in Patients Treated With or Without Revascularization

NCT04223089

TERMINATED NA

Analgesic Effect of Music Listening During Pain Elicitation in Fibromyalgia

NCT04059042

COMPLETED Phase 4

Multimodal Pain Study in Free Flap Patients

NCT04246697

COMPLETED NA

Dementia Risk and Dynamic Response to Exercise

NCT04009629

COMPLETED NA

Therapeutic Diets in Alzheimer's Disease

NCT03860792

COMPLETED

Mood Disorders Bladder Cancer

NCT04036877

COMPLETED NA

Diabetes Prevention Program Feasibility Study of Breastfeeding

NCT04021602

COMPLETED NA

Changing Talk Online (CHATO) Study

NCT03849937

COMPLETED NA

Effects of Passive Heat Therapy on Oxygen Consumption and Cardiovascular Fitness in Adults

NCT04026126

COMPLETED NA

SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid

NCT03954210

COMPLETED NA

Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study

NCT03976336

COMPLETED Phase 4

iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children

NCT03815019

COMPLETED NA

Heat Therapy for Fibromyalgia

NCT03768947

COMPLETED Phase 1

Encouraging Cognitive Screenings at African American Churches

NCT05037578

COMPLETED NA

Vitamin C Supplement for Lumbar Spine Surgery

NCT03918694

COMPLETED Phase 4

Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection

NCT03880539

COMPLETED NA

Preoperative Nutritional Intervention in Head and Neck Cancer

NCT03971656

COMPLETED NA

A Task Analysis Study of DECIDE For African American Patients With Type 2 Diabetes

NCT03855449

COMPLETED Phase 3

Individualizing Pharmacotherapy for African American Smokers

NCT03897439

COMPLETED NA

Translating Neuroscience to Population Health

NCT03976427

COMPLETED

Evaluation of MyoStrain™ in Clinical Practice

NCT03825224

COMPLETED NA

Nutrition Interventions for Cognitive Enhancement

NCT03841539

COMPLETED

Helping Moms Who Smoke

NCT03104452

COMPLETED NA

Cognitive Adaptations to Reduce Emotional Stress Associated With Type 1 Diabetes

NCT03698708

← Previous Page 5 of 9 Next →

Phase Distribution

PhaseTrial count
Phase 1 40
Phase 2 45
Phase 3 9
Phase 4 19

What is open in the University of Kansas Medical Center pipeline

93 recruiting of 408 indexed (23% open); 252 completed (62%).

Phase mix: 28 late (III/IV) vs 85 early (I/II) (early-phase heavy).

Top condition: Smoking Cessation (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Kansas Medical Center: open-pipeline peers nationwide

Peers matched on 408 registered trials and 23% open enrollment, not the therapeutic-area sidebar.

University of Kansas Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 10%15%20%25% Total trials Recruiting share University of Kansas Medical CenterTakedaCase Comprehensive Cancer CenterUniversity of NebraskaSt. Jude Children's Research HospitalVeterans Medical Research FoundationUniversity of DelawareUniversity of Texas at AustinOhio State University Comprehensive Cancer Center
University of Kansas Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Kansas Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 408 trials (± recruiting share)

Sponsors near 23% open enrollment (± trial volume)

What to do with this University of Kansas Medical Center page

408 registered trials is a research-attention snapshot, not an endorsement of University of Kansas Medical Center or any single study.

  • 93 of University of Kansas Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Smoking Cessation is the condition University of Kansas Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Smoking Cessation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Kansas Medical Center pipeline card: 408 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.